Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Kitajima

Showing results (91-100 of 242) with videos related to

Pageof 25
Sort By:
Japanese Journal of Radiology|January 19, 2023
Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment responseKuniyasu Moridera, Kazuhiro Kitajima, Kyohei Yoshikawa, et al.
Japanese Journal of Radiology|September 30, 2011
Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumorsKazuhiro Kitajima, Yoshiko Ueno, Tetsuo Maeda, et al.
Molecular Imaging and Biology|December 2, 2009
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CTKazuhiro Kitajima, Koji Murakami, Erena Yamasaki, et al.
Hellenic Journal of Nuclear Medicine|April 6, 2025
Utility of <sup>18</sup>F-FDG PET/CT in risk assessment of Medication-related osteonecrosis of jawKazuhiro Kitajima, Kazuma Noguchi, Kuniyasu Moridera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2008
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CTKazuhiro Kitajima, Koji Murakami, Erena Yamasaki, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2010
Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrenceKazuhiro Kitajima, Kayo Suzuki, Yuji Nakamoto, et al.
Hellenic Journal of Nuclear Medicine|August 1, 2023
Effects of CT-based attenuation correction on quantitative SPECT/CT of jawboneTatsuya Tsuchitani, Kazuhiro Kitajima, Yoshiyuki Takahashi, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
Comparison of Conventional Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnostic Accuracy of Staging in Patients with Intrahepatic CholangiocarcinomaEiko Nishioka, Masakatsu Tsurusaki, Ryohei Kozuki, et al.
Japanese Journal of Radiology|December 17, 2015
[(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CTYuko Suenaga, Kazuhiro Kitajima, Tomonori Kanda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2008
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CTKazuhiro Kitajima, Koji Murakami, Erena Yamasaki, et al.
Pageof 25

Showing results (91-100 of 242) with videos related to

Sort By:
Pageof 25
Japanese Journal of Radiology|January 19, 2023
Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment responseKuniyasu Moridera, Kazuhiro Kitajima, Kyohei Yoshikawa, et al.
Japanese Journal of Radiology|September 30, 2011
Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumorsKazuhiro Kitajima, Yoshiko Ueno, Tetsuo Maeda, et al.
Molecular Imaging and Biology|December 2, 2009
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CTKazuhiro Kitajima, Koji Murakami, Erena Yamasaki, et al.
Hellenic Journal of Nuclear Medicine|April 6, 2025
Utility of <sup>18</sup>F-FDG PET/CT in risk assessment of Medication-related osteonecrosis of jawKazuhiro Kitajima, Kazuma Noguchi, Kuniyasu Moridera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2008
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CTKazuhiro Kitajima, Koji Murakami, Erena Yamasaki, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2010
Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrenceKazuhiro Kitajima, Kayo Suzuki, Yuji Nakamoto, et al.
Hellenic Journal of Nuclear Medicine|August 1, 2023
Effects of CT-based attenuation correction on quantitative SPECT/CT of jawboneTatsuya Tsuchitani, Kazuhiro Kitajima, Yoshiyuki Takahashi, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
Comparison of Conventional Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnostic Accuracy of Staging in Patients with Intrahepatic CholangiocarcinomaEiko Nishioka, Masakatsu Tsurusaki, Ryohei Kozuki, et al.
Japanese Journal of Radiology|December 17, 2015
[(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CTYuko Suenaga, Kazuhiro Kitajima, Tomonori Kanda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2008
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CTKazuhiro Kitajima, Koji Murakami, Erena Yamasaki, et al.
Pageof 25